Inspire Medical Systems
INSP
67.45
-0.75
-1.10%
Inspire Medical Systems
US · INSP
#2781 by market cap
Listed 2018
67.45
-0.75
-1.10%
Live - 5344 symbols - heartbeat 119s ago
· 2026-10-08 08:21
Pre-market
67.30
-0.22%
After-hours
67.45
0.00%
- Market cap
- 1.95B
- P/E (TTM)i
- 14.89
- P/Bi
- 2.36
- EPSi
- 4.89
- Div yieldi
- 0.00%
- 52W posi
- 26%
Reader sentiment
Are you bullish or bearish on INSP?
Anonymous reader poll. Unscientific, not investment advice.
Recent news
-
Rating change
Freedom Capital Markets Initiates Inspire Medical Systems(INSP.US) With Buy Rating, Announces Target Price $62Market Newswire · 2026/7/2
-
Rating change
Wells Fargo Maintains Inspire Medical Systems(INSP.US) With Hold Rating, Cuts Target Price to $56Market Newswire · 2026/5/6
-
RBC Capital Maintains Inspire Medical Systems(INSP.US) With Hold Rating, Raises Target Price to $75Market Newswire · 2026/10/1
-
RBC Capital Initiates Inspire Medical Systems(INSP.US) With Hold Rating, Announces Target Price $75Market Newswire · 2026/10/3
-
Rating change
KeyBanc Maintains Inspire Medical Systems(INSP.US) With Hold RatingMarket Newswire · 2026/8/4
-
Rating change
J.P. Morgan Remains a Hold on Inspire Medical Systems (INSP)TipRanks · 2026/8/4
-
Rating change
Truist Financial Maintains Inspire Medical Systems(INSP.US) With Hold Rating, Cuts Target Price to $54Market Newswire · 2026/7/16
-
Stifel Maintains Inspire Medical Systems(INSP.US) With Buy Rating, Maintains Target Price $80Market Newswire · 2026/9/14
-
Company notice
Puyuan Information: Independent financial adviser's opinion of Minsheng Securities Co., Ltd. on insider information related to Puyuan Information Technology Co., Ltd.'s termination of major asset restructuring matters and stock trading during the self-inspSZSI · 2021/3/24
-
Freedom Capital Markets Maintains Inspire Medical Systems(INSP.US) With Buy Rating, Raises Target Price to $97Market Newswire · 2026/9/21
-
Rating change
Oppenheimer Maintains Inspire Medical Systems(INSP.US) With Hold RatingMarket Newswire · 2026/5/7
-
Rating change
UBS Downgrades Inspire Medical Systems(INSP.US) to Sell Rating, Cuts Target Price to $39Market Newswire · 2026/7/28
-
Rating change
A Quick Look at Today's Ratings for Inspire Medical Systems(INSP.US), With a Forecast Between $45 to $85Market Newswire · 2026/8/5
-
Rating change
Wells Fargo Maintains Inspire Medical Systems(INSP.US) With Hold Rating, Maintains Target Price $56Market Newswire · 2026/7/4
-
Rating change
Mizuho Securities Maintains Inspire Medical Systems(INSP.US) With Buy Rating, Cuts Target Price to $55Market Newswire · 2026/5/5
-
Rating change
BofA Securities Downgrades Inspire Medical Systems(INSP.US) to Sell Rating, Cuts Target Price to $39Market Newswire · 2026/5/22
-
Rating change
A Quick Look at Today's Ratings for Inspire Medical Systems(INSP.US), With a Forecast Between $55 to $65Market Newswire · 2026/5/5
-
Rating change
Evercore Maintains Inspire Medical Systems(INSP.US) With Buy Rating, Cuts Target Price to $55Market Newswire · 2026/5/5
-
Stifel Maintains Inspire Medical Systems(INSP.US) With Buy Rating, Raises Target Price to $85Market Newswire · 2026/9/23
-
Rating change
Stifel Maintains Inspire Medical Systems(INSP.US) With Buy Rating, Raises Target Price to $80Market Newswire · 2026/9/11
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-10-08 08:21:38 · For reference only, not investment advice and not tailored to your situation.